Home | Welcome to Contract Pharma   
Last Updated Friday, May 24 2013
Print

Financial Report: Akorn 3Q



Published October 31, 2006
Related Searches: Financial Reports
Akorn Inc. Third Quarter Report

3Q Revenues:
$14.5 million (+32%)

3Q Loss: $1.2 million (loss of $3.6 million in 3Q2005)

YTD Revenues: $56.7 million (+68%)

YTD Loss: $0.6 million (loss of $8.0 million in YTD2005)

Comments: Two new contract manufacturing supply agreements were signed, one with GeneraMedix and one with Advanced Vision Research.The two agreements are projected to increase Contract Manufacturing sales by approximately 50% on an annualized basis, beginning in 2007. They are expected to contribute revenue in the fourth quarter of 2006.


blog comments powered by Disqus
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On